EQ
Equillium, Inc.NASDAQHealthcare$1.97+2.03%ClosedMarket Cap: $70.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
6.46
P/S
0.00
EV/EBITDA
-1.81
DCF Value
$0.32
FCF Yield
-31.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-119.2%
ROA
-70.2%
ROIC
-83.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-4.0M | $-3.8M | $-0.04 | — |
| FY 2025 | $130.0K | 50.0% | $-23.6M | $-22.4M | $-0.39 | — |
| Q3 2025 | $0.00 | -Infinity% | $-4.6M | $-4.2M | $-0.12 | — |
| Q2 2025 | $0.00 | -Infinity% | $-6.2M | $-5.7M | $-0.16 | — |
| Q1 2025 | $0.00 | NaN% | $-8.9M | $-8.7M | $-0.24 | — |
| Q4 2024 | $4.4M | 100.0% | $-4.7M | $-5.8M | $-0.16 | — |
| FY 2024 | $41.1M | 100.0% | $-8.3M | $-8.1M | $-0.23 | — |
| Q3 2024 | $12.2M | 100.0% | $-679.0K | $-7.0K | $-0.00 | — |
| Q2 2024 | $13.9M | 100.0% | $-100.0K | $468.0K | $0.01 | — |
| Q1 2024 | $10.7M | 99.7% | $-2.8M | $-2.7M | $-0.08 | — |
| Q4 2023 | $9.2M | 99.6% | $-3.2M | $-2.3M | $-0.07 | — |
| FY 2023 | $36.1M | 100.0% | $-14.5M | $-13.3M | $-0.38 | — |